Moderna Inc (MRNA)

$121.15 0.01 (0.01%)

10:20 EDT MRNA Stock Quote Delayed 30 Minutes

3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition

By Andy Kim, InvestorPlace Contributor Jul 18, 2024

These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late.

3 Biotech Stocks to Buy in Case of Another Pandemic

3 Pharma Stocks That Could Make Your Grandchildren Rich

3 Healthcare Stocks to Sell in July Before They Crash & Burn

Volume:

Previous Close -

Market Cap 46.40B

PE Ratio -7.74

EPS -15.66

Volume (Avg. Vol.) 264,841

Day's Range $120.44 - $124.06

52-Week Range $62.55 - $170.47

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

3 Biotech Stocks to Sell in July Before They Crash & Burn

By Andy Kim, InvestorPlace Contributor Jul 5, 2024

While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late

3 Biotech Stocks Turning DNA Dreams Into Dollars

By Viktor Zarev, InvestorPlace Contributor Jul 5, 2024

Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet

By Joey Frenette, InvestorPlace Contributor Jun 28, 2024

Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.

7 Struggling Stocks to Sell Before July 2024

By Ian Bezek, InvestorPlace Contributor Jun 12, 2024

The stock market is riding high for now. But even a roaring bull market can't save these seven stocks to sell.

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants

By Hope Mutie, InvestorPlace Contributor Jun 11, 2024

After the FDA's authorization of a Covid19 booster shot, you may want to consider adding these vaccine stocks to your portfolio.

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential

By Vandita Jadeja Jun 5, 2024

If you have the patience and the ability to take a little risk, consider these three biotech stocks to buy since they can really pay off.

3 Sorry Biotech Stocks to Sell in May While You Still Can

By Muslim Farooque, InvestorPlace Contributor May 31, 2024

Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.

3 Nasdaq Stocks to Dump as They Near Peak Performance

By Stavros Tousios, InvestorPlace Contributor May 30, 2024

Moderna, Constellation Energy and CrowdStrike are three Nasdaq stocks to sell, each offering unique exit points in a peaking market.

3 Sorry Pharma Stocks to Sell in May While You Still Can

By Matthew Farley, InvestorPlace Contributor May 29, 2024

Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names

By Chandler Capital, InvestorPlace Contributor May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts

By Shrey Dua, InvestorPlace Assistant News Writer May 23, 2024

MRNA stock has climbed more than 20% in just the past five trading sessions. What's behind Moderna's recent rally?

3 Cathie Wood Stocks to Buy Now: May 2024

By Joey Frenette, InvestorPlace Contributor May 21, 2024

Many popular stocks are down, but it may be a mistake to discount these Cathie Wood stocks to buy as new catalysts come to be.

Just Say No to Drugs: 3 Pharma Stocks to Avoid

By Shane Neagle, InvestorPlace Contributor May 8, 2024

Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

By Matthew Farley, InvestorPlace Contributor May 3, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

MRNA stock results show that Moderna beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks

By Ian Bezek, InvestorPlace Contributor May 2, 2024

Current economic tides have turned against Cathie Wood's style of aggressive investing, with three of her picks in particular danger.

Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar

By Joey Frenette, InvestorPlace Contributor May 1, 2024

These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.

3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition

By Chandler Capital, InvestorPlace Contributor Apr 30, 2024

Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.

Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 23, 2024

While artificial intelligence may be useful for a variety of purposes – including asking silly questions we’re afraid to pose in real life – the…

3 Pharma Stocks to Sell in April Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Apr 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

Moderna Inc (MRNA)

3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition

3 Biotech Stocks to Buy in Case of Another Pandemic

3 Pharma Stocks That Could Make Your Grandchildren Rich

3 Healthcare Stocks to Sell in July Before They Crash & Burn

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in